Bio Special

Combatting Cancer Disparities: Addressing Challenges and Expanding Access to Care in Low- and Middle-Income Countries

In an exclusive email interview with BioPharma APAC, Carmen Auste, the CEO of Cancer Warriors Foundation Philippines and Vice President of Cancer Coalition...

 December 13, 2023 | News

IQVIA Experts Share Perspectives on Challenges, Opportunities, and the Transformative Role of DCTs in Asia Pacific

In a dynamically evolving landscape of clinical research, the Asia Pacific (APAC) region has emerged as a key player in adopting Decentralized Clinical Tri...

 December 13, 2023 | News

Addressing the Dengue Crisis in Southeast Asia: Insights from Prof. Tikki Pangestu and Prof. Lulu Bravo

In this exclusive interview, BioPharma APAC engage with two distinguished experts in the field of infectious diseases and immunization: Prof. Tikki Pangest...

 December 04, 2023 | News

Combatting Cancer Misinformation: Insights from Ranjit Kaur, Breast Cancer Advocate and APOA Advisory Board Member

In an exclusive interaction, Ranjit Kaur, Immediate Past President of the Breast Cancer Welfare Association Malaysia and Advisory Board Member of the Asia ...

 December 04, 2023 | News

Asia Pacific Oncology Alliance Report Emphasizes Patient Collaboration for Improved Cancer Care

Report highlights fundamental shift in treatment for cancer, from a terminal to a chronic  disease that can be treated and managed   Expl...

 December 04, 2023 | News

Roche's Ying Ying Yeoh Explores the Power of Public-Private Partnerships in Shaping Healthcare's Future in Asia Pacific

    Ying Ying Yeoh, a key figure at Roche, shares insights into the transformative impact of public-private partnerships (PPPs) on healthcare i...

 November 29, 2023 | News

Is Asia ready to be the next global biotech hub?

  As outlined in Cytiva’s 2023 Global Biopharma Resilience Index, economies such as Singapore, South Korea, Japan and Australia, are able to pr...

 November 28, 2023 | Opinion | By Prem Mandalapu, Commercial General Manager, ASEAN, Cytiva

Pioneering a New Era in Biopharmaceuticals: Hilleman Laboratories' CEO, Raman Rao, Showcases Cutting-edge ACES Facility and Global Health Initiatives

In an exclusive interview with BioPharma APAC, Raman Rao, the Chief Executive Officer of Hilleman Laboratories Singapore, delves into the transformative ca...

 November 27, 2023 | News

In Conversation with Eugene Kang: Pioneering the Future of Cell Therapy with Thermo Fisher's CTS Detachable Dynabeads

In an exclusive Q&A by BioPharma APAC  with Eugene Kang, Senior Product Manager for Cell Therapy at Thermo Fisher Scientific, we delve into the gr...

 November 15, 2023 | News

Hong Chow discusses Merck's ambitious €25 billion sales goal, sustainability initiatives, innovation priorities, and fostering a high-impact culture in the Asia-Pacific region

In an exclusive interview by BioPharma APAC , Hong Chow, Executive Vice President and Head of China & International for Merck's Healthcare business, pr...

 November 14, 2023 | News

Amgen's Serene Chang Discusses the Battle Against Osteoporosis in Asia-Pacific: Insights on High Fracture Rates and Collaborative Solutions

In an exclusive exchange, BioPharma APAC engaged in a conversation with Serene Chang, General Manager of Amgen Singapore and Malaysia, delving into the sig...

 October 26, 2023 | News

Merck Validation Lab: An Inside Look with Mr. Ramesh Raju, Head of Operations BioReliance Validation Services

In an exclusive interview with BioPharma APAC, Mr. Ramesh Raju, Head of Operations for BioReliance Validation Services at Merck Validation Lab, sheds light...

 October 24, 2023 | News

Shaping a Sound Future: WS Audiology's Olivier Chupin on Hearing Health in the Asia Pacific Region

The Asia Pacific region is on the cusp of a demographic transformation, with the aging population set to expand dramatically by 2050. Amid this unprecedent...

 October 18, 2023 | News

Dirk Lange Reveals Merck's Historic Leap as the First CTDMO to Offer Integrated mRNA Services: A Blueprint for Advancing Biopharma

In this interview, we explore the significance of Merck's €1 billion investment in advancing mRNA technologies, the impact of their acqu...

 October 11, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close